AtomVie is a lifecycle radiopharmaceutical CDMO supporting partners from process development through clinical production to commercial manufacturing. Built on a proven track record of reliable global delivery and renowned technical expertise in process and analytical development, AtomVie has consistently delivered under constrained environments now amplified by a purpose-built, 72,300 sq. ft. high-capacity commercial facility.
With over 99% delivery success in reaching patients globally, deep scientific expertise, and a flexible partner offering, AtomVie enables seamless progression from early development to commercial manufacturing of radiopharmaceuticals. AtomVie not only helps you succeed in Phase I and II; we scale with you as you excel in Phase III development and reach the marketplace to deliver radiopharmaceuticals to patients.
AtomVie has evolved over the last decade; our team holds over 60 years of combined radiopharmaceutical experience and over two centuries worth in pharma, with a successful track record in the development of next-generation radiotherapeutics.
AtomVie offers a wide range of services for development, manufacturing, and regulatory approvals. Our highly skilled team boasts a strong track record with results that speak for themselves:
